品牌咨询
联系方式
公司地址
苏州工业园区生物纳米园A4#216
联系电话
4000-520-616 / 18915418616
传真号码
0512-67156496
电子邮箱
info@ebiomall.com
公司网址
https://www.ebiomall.com

yesbiotech/mAb anti-Human GP IIb/IIIa, 291/0.1 mg/MO-M40040J

价格
¥3600.00
货号:MO-M40040J
浏览量:127
品牌:yesbiotech
服务
全国联保
正品保证
正规发票
签订合同
商品描述
  • Description
  • Additional

Description

Details

Description:Mouse monoclonal antibody to human platelet membrane glycoprotein IIb/IIIa (GP IIb/IIIa)

Purification:Protein G affinity purified

Product Type: Primary antibody

Target Protein:Human platelet membrane glycoprotein IIb/IIIa

Immunogen:Human platelet suspension

Fusion Myeloma:Sp2/0-Ag14

Specificity:The mAb reacts with human platelet.

Species Reacitvity:Human, others not tested

Host / Isotype:Mouse, IgG2b Kappa

Formulation:Lyophilized from a solution in 0.01M PBS, pH 7.2

Reconstitution:Double distilled water is recommended to adjust the final concentration to 1.00mg/mL.

Storage: Store at -20oC

Research Area:Hematology, blood coagulation

Background:

Human platelet membrane glycoprotein Glycoprotein IIb/IIIa (GP IIb/IIIa) is a dominate receptor on the platelet membrane with very high molecular weight (>200kDa). After the platelet is activated, the GP IIb/IIIa receptor complex changes conformation and binds to fibrinogen in blood circulation with high affinity. The activation of platelets is initiated locally when the endothelial layer is wounded and the platelets are exposed to the collagen underneath the endothelium. The fibrinogen aggregates with platelets when binding to the GP IIb/IIIa receptor on platelets, thus primary haemostasis (Platelet clot) is formed.

Application:

ELISA:The mAb is reactive to platelet coated ELISA plate.

Other applications have not been evaluated.

References:

If research is published using this product, please inform Anogen in order to cite the reference on this datasheet. Anogen will provide one unit of product in the same category as gratitude.

Additional

Additional Information

Product SpecificitymAb anti-Human GP IIb/IIIa, 291
ApplicationEIA
Size0.1 mg
yesbiotech自2009年以来,我们一直在开发针对AD的基于抗体的疗法,并针对多种淀粉样β(Aβ)肽产生了70多种单克隆抗体(mAb)。这些单克隆抗体中的三个(3F5、6C8和1H3)已显示出在小鼠模型中预防AD进展的功效。我们还开发了一种ELISA试剂盒,用于定量测量AD的主要病因Aβ42。我们的AD前项目是首次尝试通过鼻内途径将抗Aβ42单抗用于AD预防和治疗。